Cargando…
VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer
BACKGROUND: VirtUaL ChIP-seq Analysis through Networks (VULCAN) infers regulatory interactions of transcription factors by overlaying networks generated from publicly available tumor expression data onto ChIP-seq data. We apply our method to dissect the regulation of estrogen receptor-alpha activati...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515683/ https://www.ncbi.nlm.nih.gov/pubmed/31084623 http://dx.doi.org/10.1186/s13059-019-1698-z |
_version_ | 1783418132037107712 |
---|---|
author | Holding, Andrew N. Giorgi, Federico M. Donnelly, Amanda Cullen, Amy E. Nagarajan, Sankari Selth, Luke A. Markowetz, Florian |
author_facet | Holding, Andrew N. Giorgi, Federico M. Donnelly, Amanda Cullen, Amy E. Nagarajan, Sankari Selth, Luke A. Markowetz, Florian |
author_sort | Holding, Andrew N. |
collection | PubMed |
description | BACKGROUND: VirtUaL ChIP-seq Analysis through Networks (VULCAN) infers regulatory interactions of transcription factors by overlaying networks generated from publicly available tumor expression data onto ChIP-seq data. We apply our method to dissect the regulation of estrogen receptor-alpha activation in breast cancer to identify potential co-regulators of the estrogen receptor’s transcriptional response. RESULTS: VULCAN analysis of estrogen receptor activation in breast cancer highlights the key components of the estrogen receptor complex alongside a novel interaction with GRHL2. We demonstrate that GRHL2 is recruited to a subset of estrogen receptor binding sites and regulates transcriptional output, as evidenced by changes in estrogen receptor-associated eRNA expression and stronger estrogen receptor binding at active enhancers after GRHL2 knockdown. CONCLUSIONS: Our findings provide new insight into the role of GRHL2 in regulating eRNA transcription as part of estrogen receptor signaling. These results demonstrate VULCAN, available from Bioconductor, as a powerful predictive tool. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13059-019-1698-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6515683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65156832019-05-21 VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer Holding, Andrew N. Giorgi, Federico M. Donnelly, Amanda Cullen, Amy E. Nagarajan, Sankari Selth, Luke A. Markowetz, Florian Genome Biol Research BACKGROUND: VirtUaL ChIP-seq Analysis through Networks (VULCAN) infers regulatory interactions of transcription factors by overlaying networks generated from publicly available tumor expression data onto ChIP-seq data. We apply our method to dissect the regulation of estrogen receptor-alpha activation in breast cancer to identify potential co-regulators of the estrogen receptor’s transcriptional response. RESULTS: VULCAN analysis of estrogen receptor activation in breast cancer highlights the key components of the estrogen receptor complex alongside a novel interaction with GRHL2. We demonstrate that GRHL2 is recruited to a subset of estrogen receptor binding sites and regulates transcriptional output, as evidenced by changes in estrogen receptor-associated eRNA expression and stronger estrogen receptor binding at active enhancers after GRHL2 knockdown. CONCLUSIONS: Our findings provide new insight into the role of GRHL2 in regulating eRNA transcription as part of estrogen receptor signaling. These results demonstrate VULCAN, available from Bioconductor, as a powerful predictive tool. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13059-019-1698-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-13 /pmc/articles/PMC6515683/ /pubmed/31084623 http://dx.doi.org/10.1186/s13059-019-1698-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Holding, Andrew N. Giorgi, Federico M. Donnelly, Amanda Cullen, Amy E. Nagarajan, Sankari Selth, Luke A. Markowetz, Florian VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer |
title | VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer |
title_full | VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer |
title_fullStr | VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer |
title_full_unstemmed | VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer |
title_short | VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer |
title_sort | vulcan integrates chip-seq with patient-derived co-expression networks to identify grhl2 as a key co-regulator of era at enhancers in breast cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515683/ https://www.ncbi.nlm.nih.gov/pubmed/31084623 http://dx.doi.org/10.1186/s13059-019-1698-z |
work_keys_str_mv | AT holdingandrewn vulcanintegrateschipseqwithpatientderivedcoexpressionnetworkstoidentifygrhl2asakeycoregulatoroferaatenhancersinbreastcancer AT giorgifedericom vulcanintegrateschipseqwithpatientderivedcoexpressionnetworkstoidentifygrhl2asakeycoregulatoroferaatenhancersinbreastcancer AT donnellyamanda vulcanintegrateschipseqwithpatientderivedcoexpressionnetworkstoidentifygrhl2asakeycoregulatoroferaatenhancersinbreastcancer AT cullenamye vulcanintegrateschipseqwithpatientderivedcoexpressionnetworkstoidentifygrhl2asakeycoregulatoroferaatenhancersinbreastcancer AT nagarajansankari vulcanintegrateschipseqwithpatientderivedcoexpressionnetworkstoidentifygrhl2asakeycoregulatoroferaatenhancersinbreastcancer AT selthlukea vulcanintegrateschipseqwithpatientderivedcoexpressionnetworkstoidentifygrhl2asakeycoregulatoroferaatenhancersinbreastcancer AT markowetzflorian vulcanintegrateschipseqwithpatientderivedcoexpressionnetworkstoidentifygrhl2asakeycoregulatoroferaatenhancersinbreastcancer |